L. Koeb

422 total citations
16 papers, 342 citations indexed

About

L. Koeb is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, L. Koeb has authored 16 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in L. Koeb's work include Epilepsy research and treatment (5 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). L. Koeb is often cited by papers focused on Epilepsy research and treatment (5 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). L. Koeb collaborates with scholars based in Switzerland. L. Koeb's co-authors include Pierre Baumann, Chin B. Eap, Michèle Jonzier-Perey, Kerry Powell, Dominique Baettig, Marlyse Brawand-Amey, M. Stabl, M. Amey, C. Uehlinger and Séverine Crettol and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Pharmaceutical and Biomedical Analysis and Journal of Clinical Psychopharmacology.

In The Last Decade

L. Koeb

16 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Koeb Switzerland	11	164	94	72	67	64	16	342
Yukiya Saitoh Japan	13	101 0.6×	78 0.8×	53 0.7×	120 1.8×	52 0.8×	56	458
Kerry Powell Switzerland	13	189 1.2×	135 1.4×	92 1.3×	54 0.8×	133 2.1×	15	533
Takako Osanai Japan	11	136 0.8×	133 1.4×	109 1.5×	46 0.7×	30 0.5×	16	362
Jian Fang China	11	144 0.9×	80 0.9×	105 1.5×	60 0.9×	54 0.8×	18	471
Gregory M. Kochak Switzerland	12	89 0.5×	60 0.6×	76 1.1×	76 1.1×	55 0.9×	34	483
K. Sugawara Japan	14	174 1.1×	152 1.6×	121 1.7×	92 1.4×	42 0.7×	29	537
George J. Wright United States	13	70 0.4×	97 1.0×	61 0.8×	61 0.9×	49 0.8×	34	439
T. W. Guentert Switzerland	15	157 1.0×	233 2.5×	86 1.2×	71 1.1×	46 0.7×	28	517
Jolanta Widén Sweden	9	297 1.8×	114 1.2×	108 1.5×	67 1.0×	41 0.6×	9	488
DD Breimer Netherlands	15	270 1.6×	89 0.9×	74 1.0×	81 1.2×	87 1.4×	21	689

Countries citing papers authored by L. Koeb

Since Specialization

Citations

This map shows the geographic impact of L. Koeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Koeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Koeb more than expected).

Fields of papers citing papers by L. Koeb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Koeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Koeb. The network helps show where L. Koeb may publish in the future.

Co-authorship network of co-authors of L. Koeb

This figure shows the co-authorship network connecting the top 25 collaborators of L. Koeb. A scholar is included among the top collaborators of L. Koeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Koeb. L. Koeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Uehlinger, C., et al.. (2007). Increased (R)-Methadone Plasma Concentrations by Quetiapine in Cytochrome P450s and ABCB1 Genotyped Patients. Journal of Clinical Psychopharmacology. 27(3). 273–278. 42 indexed citations

Eap, Chin B., et al.. (1996). Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin*. Clinical Pharmacology & Therapeutics. 59(3). 322–331. 45 indexed citations

Eap, Chin B., L. Koeb, Kerry Powell, & Pierre Baumann. (1995). Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 669(2). 271–279. 37 indexed citations

Eap, Chin B., L. Koeb, & Pierre Baumann. (1994). Determination of trimipramine and its demethylated and hydroxylated metabolites in plasma by gas chromatography—mass spectrometry.. Journal of Chromatography B Biomedical Sciences and Applications. 652(1). 97–103. 6 indexed citations

Eap, Chin B., L. Koeb, & Pierre Baumann. (1993). Artifacts in the analysis of thioridazine and other neuroleptics. Journal of Pharmaceutical and Biomedical Analysis. 11(6). 451–457. 19 indexed citations

Baumann, Pierre, et al.. (1993). [Treatment of depression by a combination of clomipramine and triiodothyronine].. PubMed. 17(1). 37–42. 3 indexed citations

Eap, Chin B., et al.. (1992). Plasma Levels of Trimipramine and Metabolites in Four Patients. Therapeutic Drug Monitoring. 14(5). 380–385. 16 indexed citations

Baumann, Pierre, et al.. (1992). Dextromethorphan and Mephenytoin Phenotyping of Patients Treated with Thioridazine or Amitriptyline. Therapeutic Drug Monitoring. 14(1). 1–8. 53 indexed citations

Eap, Chin B., et al.. (1992). Influence of Quinidine on the Pharmacokinetics of Trimipramine and on Its Effect on the Waking EEG of Healthy Volunteers. Neuropsychobiology. 25(4). 214–220. 15 indexed citations

10.

Eap, Chin B., et al.. (1991). Light-Induced Racemization. Therapeutic Drug Monitoring. 13(4). 356–362. 16 indexed citations

11.

Baumann, Pierre, et al.. (1988). Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoin.. PubMed. 38(2). 292–6. 2 indexed citations

12.

Baumann, Pierre, et al.. (1986). Pharmacogenetics of antidepressive drugs. IRIS. 1 indexed citations

13.

Baumann, Pierre, et al.. (1986). Amitriptyline Pharmacokinetics and Clinical Response: 1. Free and Total Plasma Amitriptyline and Nortriptyline. International Clinical Psychopharmacology. 1(2). 89–101. 18 indexed citations

14.

Baumann, Pierre, et al.. (1986). Amitriptyline Pharmacokinetics and Clinical Response: II. Metabolic Polymorphism Assessed by Hydroxylation of Debrisoquine and Mephenytoin. International Clinical Psychopharmacology. 1(2). 102–112. 56 indexed citations

15.

Baumann, Pierre, et al.. (1985). [The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study].. PubMed. 115(33). 1128–34. 1 indexed citations

16.

Baumann, Pierre, et al.. (1982). On the Relationship between Free Plasma and SalivaAmitriptyline and Nortriptyline. International Pharmacopsychiatry. 17(3). 136–146. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact